We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content.

For more information visit our privacy policy.

Luminex Corp Sample Contracts

Standard Contracts

FORM OF] STOCK OPTION AGREEMENT FOR THE GRANT OF STOCK OPTIONS
Stock Option Agreement • February 7th, 2000 • Luminex Corp
FORM OF]
Incentive Stock Option Agreement • February 7th, 2000 • Luminex Corp
FORM OF
Underwriting Agreement • March 27th, 2000 • Luminex Corp • Services-commercial physical & biological research • New York
EXHIBIT 10.18 LEASE AGREEMENT
Lease Agreement • November 13th, 2001 • Luminex Corp • Services-commercial physical & biological research • Texas
BY AND AMONG
Asset Purchase Agreement • September 10th, 2002 • Luminex Corp • Services-commercial physical & biological research • Delaware
WITNESSETH:
Executive Employment Agreement • March 16th, 2006 • Luminex Corp • Services-commercial physical & biological research
LUMINEX CORPORATION AND WILMINGTON TRUST, NATIONAL ASSOCIATION, as Trustee INDENTURE Dated as of May 13, 2020 3.00% Convertible Senior Notes due 2025
Indenture • May 13th, 2020 • Luminex Corp • Surgical & medical instruments & apparatus • New York

INDENTURE dated as of May 13, 2020 between LUMINEX CORPORATION, a Delaware corporation, as issuer (the “Company,” as more fully set forth in Section 1.01) and WILMINGTON TRUST, NATIONAL ASSOCIATION, a national banking association, as trustee (the “Trustee,” as more fully set forth in Section 1.01).

FORM OF AMENDED AND RESTATED EMPLOYMENT AGREEMENT
Employment Agreement • August 14th, 2002 • Luminex Corp • Services-commercial physical & biological research • Texas
Exhibit 10.15 FORM OF EMPLOYMENT AGREEMENT
Employment Agreement • March 13th, 2000 • Luminex Corp • Services-commercial physical & biological research • Texas
LEASE AMENDMENT
Lease Amendment • March 31st, 2003 • Luminex Corp • Services-commercial physical & biological research
AND
Rights Agreement • June 21st, 2001 • Luminex Corp • Services-commercial physical & biological research • New York
Dealer]
Call Option Transaction • May 13th, 2020 • Luminex Corp • Surgical & medical instruments & apparatus

The purpose of this letter agreement (this “Confirmation”) is to confirm the terms and conditions of the call option transaction entered into between [Dealer] (“Dealer”) and Luminex Corporation (“Counterparty”) as of the Trade Date specified below (the “Transaction”). This letter agreement constitutes a “Confirmation” as referred to in the ISDA Master Agreement specified below. Each party further agrees that this Confirmation together with the Agreement evidence a complete binding agreement between Counterparty and Dealer as to the subject matter and terms of the Transaction to which this Confirmation relates, and shall supersede all prior or contemporaneous written or oral communications with respect thereto.

Dealer]
Warrant Agreement • May 13th, 2020 • Luminex Corp • Surgical & medical instruments & apparatus • New York

The purpose of this letter agreement (this “Confirmation”) is to confirm the terms and conditions of the Warrants issued by Luminex Corporation (“Company”) to [Dealer] (“Dealer”) as of the Trade Date specified below (the “Transaction”). This letter agreement constitutes a “Confirmation” as referred to in the ISDA Master Agreement specified below. Each party agrees that, as to the subject matter and terms of the Transaction to which this Confirmation relates, this Confirmation together with the Agreement (as defined below) shall supersede all prior or contemporaneous written or oral communications between Company and Dealer.

RECITAL
Employment Agreement • March 15th, 2004 • Luminex Corp • Services-commercial physical & biological research • Texas
LUMINEX CORPORATION RESTRICTED SHARE AWARD AGREEMENT (DIRECTORS)
Restricted Share Award Agreement • May 25th, 2006 • Luminex Corp • Services-commercial physical & biological research • Delaware
RECITAL
Employment Agreement • October 22nd, 2004 • Luminex Corp • Services-commercial physical & biological research • Texas
LUMINEX CORPORATION and THE BANK OF NEW YORK TRUST COMPANY, N.A., as Trustee INDENTURE Dated as of , 2008 Providing for the Issuance of Debt Securities
Indenture • June 16th, 2008 • Luminex Corp • Services-commercial physical & biological research • New York

THIS INDENTURE, between Luminex Corporation, a Delaware corporation (hereinafter called the “Company”) having its principal office at 12212 Technology Boulevard, Austin, Texas 78727, and The Bank of New York Trust Company, N.A., a national banking association, as trustee (hereinafter called the “Trustee”), is made and entered into as of this day of , 2008.

FORM OF SUPPORT AGREEMENT
Support Agreement • May 16th, 2016 • Luminex Corp • Surgical & medical instruments & apparatus • Delaware

THIS SUPPORT AGREEMENT (this “Agreement”) is made and entered into as of May 15, 2016 by and between Luminex Corporation, a Delaware corporation (“Parent”), and the undersigned stockholder (“Stockholder”) of Nanosphere, Inc., a Delaware corporation (the “Company”).

AGREEMENT AND PLAN OF MERGER BY AND AMONG: DIASORIN S.P.A. DIAGONAL SUBSIDIARY INC. AND LUMINEX CORPORATION DATED AS OF APRIL 11, 2021
Merger Agreement • April 12th, 2021 • Luminex Corp • Surgical & medical instruments & apparatus • Delaware

This AGREEMENT AND PLAN OF MERGER (“Agreement”) is made and entered into as of April 11, 2021 (the “Agreement Date”) by and among DiaSorin S.p.A., a società per azioni organized under the laws of the Republic of Italy (“Parent”), Diagonal Subsidiary Inc., a Delaware corporation and wholly owned indirect subsidiary of Parent (“Merger Subsidiary”), and Luminex Corporation, a Delaware corporation (the “Company”). Certain capitalized terms used in this Agreement are defined in Exhibit A.

RECITAL
Employment Agreement • May 18th, 2004 • Luminex Corp • Services-commercial physical & biological research • Texas
AGREEMENT AND PLAN OF MERGER among LUMINEX CORPORATION and COMMODORE ACQUISITION, INC. and NANOSPHERE, INC. dated as of May 15, 2016
Merger Agreement • May 16th, 2016 • Luminex Corp • Surgical & medical instruments & apparatus • Delaware

This Agreement and Plan of Merger (this “Agreement”), is entered into as of May 15, 2016, by and among Nanosphere, Inc., a Delaware corporation (the “Company”), Luminex Corporation, a Delaware corporation (“Parent”), and Commodore Acquisition, Inc., a Delaware corporation and a wholly-owned Subsidiary of Parent (“Merger Sub”). Capitalized terms used herein (including in the immediately preceding sentence) and not otherwise defined herein shall have the meanings set forth in Section 9.01 hereof.

EMPLOYMENT AGREEMENT
Employment Agreement • February 26th, 2019 • Luminex Corp • Surgical & medical instruments & apparatus • Texas

THIS EMPLOYMENT AGREEMENT (this “Agreement”) is made and entered into as of March 1, 2018 (the “Effective Date”) by and between Luminex Corporation, a Delaware corporation (“Luminex”) and Eric Shapiro (“Executive”).

LUMINEX CORPORATION RESTRICTED SHARE UNIT AWARD AGREEMENT (2012 LTIP)
Restricted Share Unit Award Agreement • March 13th, 2012 • Luminex Corp • Surgical & medical instruments & apparatus • Delaware

THIS RESTRICTED SHARE UNIT AWARD AGREEMENT (this “Agreement”) is made and entered into as of the __ day of _____, 2012 (the “Grant Date”), between Luminex Corporation, a Delaware corporation, (together with its Subsidiaries, the “Company”), and ________________________________ (the “Grantee”). Capitalized terms not otherwise defined herein shall have the meaning ascribed to such terms in the Luminex Corporation 2012 Long Term Incentive Plan (the “LTIP”).

UBS SECURITIES LLC LUMINEX CORPORATION 3,500,000 Shares of Common Stock Underwriting Agreement
Underwriting Agreement • June 25th, 2008 • Luminex Corp • Services-commercial physical & biological research • New York

Luminex Corporation, a Delaware corporation (the “Company”), proposes to issue and sell to the several Underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of 3,500,000 shares of common stock, par value $0.001 per share (“Common Stock”), of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional 525,000 shares of Common Stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are collectively herein referred to as the “Shares”. The shares of Common Stock of the Company to be outstanding after giving effect to the sale of the Shares are herein referred to as the “Stock”. The Stock, including the Shares, will have attached thereto rights (the “Rights”) to purchase Series A Junior Participating Preferred Stock. The Rights are to be issued pursuant to a Rights Agreement (the “Rights Agreement”) dated as of June 20, 2001 betw